Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CDK5R2 antisense RNA 1 is a long intergenic non-coding RNA (lncRNA) gene located on chromosome 2, alternatively named LINC01494[1][2][6]. It produces an antisense RNA transcript that is complementary to part of the coding strand of the CDK5R2 gene[1][2][6]. Antisense RNAs generally regulate gene expression post-transcriptionally or epigenetically, but specific biological functions, disease associations, or clinical utility for CDK5R2-AS1 have not been reported in the search results. No direct drug interactions or use as a biomarker have been established for this locus. The name and aliases are correctly attributed, and it is molecularly classified as a lncRNA gene rather than a protein, receptor, or enzyme[1][2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CDK5R2 antisense RNA 1 (CDK5R2-AS1).